A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
Clinical trial NCT02692716 · COMPLETED
Trial details
- NCT number
- NCT02692716
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-17
- Primary completion
- 2018-09-25
- Enrollment
- 3183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.